Skip to main content
. 2019 Jul 26;70(12):2663–2672. doi: 10.1093/cid/ciz704

Table 2.

Zika Virus (ZIKV)–Exposed Infant Group and Trimester of ZIKV Infection

Trimester of ZIKV Infectiona
Infant Group Infants with Laboratory-Confirmed ZIKV First Second Third P Valueb,c
Neither SGA nor microcephaly, N = 115 27 (56.3%) 58 (85.3%) 30 (93.8%)
Yes 16 (59.3%) 14(24.1%) 8 (26.7%) .004
No 11 (40.7%) 44(75.9%) 22 (73.3%)
Proportional microcephaly, N = 8 8 (16.7%) 0 (0%) 0 (0%)
Yes 5 (62.5%) 0 (0%) 0 (0%) .231
No 3 (37.5%) 0 (0%) 0 (0%)
Disproportional microcephaly, N = 12 10 (20.8%) 2 (2.9%) 0 (0%)
Yes 6 (60.0%) 0 (0%) 0 (0%) .315
No 4 (40.0%) 2 (100%) 0 (0%)
SGA, N = 13 3 (6.3%) 8 (11.8%) 2 (6.3%)
Yes 2 (66.7%) 4 (50.0%) 1 (50.0%) >.999
No 1 (33.3%) 4 (50.0%) 1 (50.0%)
Total 48 68 32
Yes 29 (60.4%) 18 (26.5%) 9 (28.1%)
No 19 (39.6%) 50 (73.5%) 23 (71.9%) <.001

Abbreviations: SGA, small for gestational age; ZIKA, Zika virus.

aTrimester of infection was unknown for 8 infants

bFisher exact test examining association between laboratory-confirmed ZIKV and trimester of infection within each infant group.

cFischer exact test was used to determine P value.